Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

527
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
527
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

1.4K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.4K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

585
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
585
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

4.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
4.4K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.4K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.4K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.8K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Liraglutide Effects in Atrial Fibrillation (LEAF) Study.

JACC. Clinical electrophysiology·2026
Same author

Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy.

American heart journal·2025
Same author

Editorial commentary: Underdosed and overlooked: Antiarrhythmic drug therapy for atrial fibrillation.

Trends in cardiovascular medicine·2025
Same author

Hospitalization trends for thromboembolic events in atrial fibrillation: A 12-year national analysis.

American heart journal plus : cardiology research and practice·2025
Same author

Long term event-free survival following cell-based therapy in patients with cardiomyopathy: the HYPERION observational cohort.

Stem cells translational medicine·2025
Same author

The atrial electrocardiogram in patients with persistent atrial fibrillation.

Heart rhythm·2025

Related Experiment Video

Updated: Apr 12, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

8.7K

Ten advances defining sudden cardiac death.

Raul D Mitrani1, Robert J Myerburg1

  • 1Division of Cardiology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL.

Trends in Cardiovascular Medicine
|May 11, 2015
PubMed
Summary

Sudden cardiac death (SCD) often presents initially in patients with heart disease, sometimes misidentified as low risk. Advances in defibrillators and genetics offer new SCD prevention strategies.

Area of Science:

  • Cardiology
  • Medical Genetics

Background:

  • Sudden cardiac death (SCD) is a critical concern, with 50% occurring as the first sign of heart disease, often in seemingly low-risk individuals.
  • The pattern of presenting dysrhythmias during cardiac arrest has shifted, with increased occurrences of pulseless electrical activity and asystole compared to ventricular tachyarrhythmias.

Purpose of the Study:

  • To review recent advances in understanding and preventing sudden cardiac death.
  • To highlight evolving diagnostic and therapeutic strategies for managing cardiac dysrhythmias and reducing SCD risk.

Main Methods:

  • Literature review of recent advancements in sudden cardiac death research.
  • Analysis of trends in presenting dysrhythmias and the impact of new defibrillator technologies.
  • Exploration of the role of medical genetics in personalized cardiac care.

More Related Videos

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest
07:02

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Published on: January 5, 2018

12.7K
Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

909

Related Experiment Videos

Last Updated: Apr 12, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

8.7K
Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest
07:02

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Published on: January 5, 2018

12.7K
Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

909

Main Results:

  • A significant portion of SCD events occur unexpectedly in individuals with underlying heart conditions.
  • Pulseless electrical activity and asystole are becoming more common presenting rhythms in cardiac arrest.
  • Implantable defibrillators, automatic external defibrillators, and wearable defibrillators represent key technological advances for SCD prevention.
  • Medical genetics offers potential for tailored therapies for inherited cardiac arrhythmia syndromes.

Conclusions:

  • Early recognition and risk stratification for SCD remain challenging.
  • Emerging defibrillator technologies expand the scope of SCD prevention.
  • Personalized medicine, driven by genetic insights, holds promise for future SCD management.